{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:15:27Z","timestamp":1791220527238,"version":"4.1.0"},"reference-count":46,"publisher":"American Association for Cancer Research (AACR)","issue":"4","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fighting metastasis is a major challenge in cancer therapy and novel therapeutic targets and drugs are highly appreciated. Resistance of invasive cells to anoikis, a particular type of apoptosis induced by loss of cell\u2013matrix contact, is a major prerequisite for their metastatic spread. Inducing anoikis in metastatic cancer cells is therefore a promising therapeutic approach. The vacuolar-ATPase (V-ATPase), a proton pump located at the membrane of acidic organelles, has recently come to focus as an antimetastatic cancer target. As V-ATPase inhibitors have shown to prevent invasion of tumor cells and are able to induce apoptosis, we proposed that V-ATPase inhibition induces anoikis-related pathways in invasive cancer cells. We used the V-ATPase inhibitor archazolid to investigate the mechanism of anoikis induction in various metastatic cancer cells (T24, MDA-MB-231, 4T1, 5637) in vitro. Anoikis induction by archazolid was characterized by decreased c-FLIP expression and caspase-8 activation as well as reduction of active integrin-\u03b21 and an early increase of the proapoptotic protein BIM. However, we observed that archazolid also induces mechanisms opposing anoikis such as degradation of BIM mediated by extracellular signal-regulated kinase (ERK), Akt and Src kinases at later time points and induction of reactive oxygen species. Still, intravenous injection of archazolid-treated 4T1-Luc2 mouse breast cancer cells resulted in reduced metastasis in mouse lungs. Thus, V-ATPase inhibition is not only an interesting option to reduce cancer metastasis, but also to better understand anoikis resistance and to find choices to fight against it. Mol Cancer Ther; 13(4); 926\u201337. \u00a92014 AACR.<\/jats:p>","DOI":"10.1158\/1535-7163.mct-13-0484","type":"journal-article","created":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T22:14:36Z","timestamp":1391120076000},"page":"926-937","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["V-ATPase Inhibition Regulates Anoikis Resistance and Metastasis of Cancer Cells"],"prefix":"10.1158","volume":"13","author":[{"given":"Christina M.","family":"Schempp","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Pharmacy, Pharmaceutical Biology and 2Department of Pharmacy, Pharmaceutical Biotechnology, University of Munich, Munich; and 3Helmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research and Department of Pharmaceutical Biotechnology, Saarland University, Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"von Schwarzenberg","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Pharmacy, Pharmaceutical Biology and 2Department of Pharmacy, Pharmaceutical Biotechnology, University of Munich, Munich; and 3Helmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research and Department of Pharmaceutical Biotechnology, Saarland University, Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Schreiner","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Pharmacy, Pharmaceutical Biology and 2Department of Pharmacy, Pharmaceutical Biotechnology, University of Munich, Munich; and 3Helmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research and Department of Pharmaceutical Biotechnology, Saarland University, Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka","family":"Kubisch","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Pharmacy, Pharmaceutical Biology and 2Department of Pharmacy, Pharmaceutical Biotechnology, University of Munich, Munich; and 3Helmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research and Department of Pharmaceutical Biotechnology, Saarland University, Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Pharmacy, Pharmaceutical Biology and 2Department of Pharmacy, Pharmaceutical Biotechnology, University of Munich, Munich; and 3Helmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research and Department of Pharmaceutical Biotechnology, Saarland University, Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Wagner","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Pharmacy, Pharmaceutical Biology and 2Department of Pharmacy, Pharmaceutical Biotechnology, University of Munich, Munich; and 3Helmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research and Department of Pharmaceutical Biotechnology, Saarland University, Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika M.","family":"Vollmar","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Pharmacy, Pharmaceutical Biology and 2Department of Pharmacy, Pharmaceutical Biotechnology, University of Munich, Munich; and 3Helmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research and Department of Pharmaceutical Biotechnology, Saarland University, Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2014,4,6]]},"reference":[{"key":"2022060800312806200_bib1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrc1670","article-title":"Breast cancer metastasis: markers and models","volume":"5","author":"Weigelt","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"2022060800312806200_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrc2622","article-title":"Metastasis: from dissemination to organ-specific colonization","volume":"9","author":"Nguyen","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"2022060800312806200_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.canlet.2008.05.029","article-title":"Anoikis resistance and tumor metastasis","volume":"272","author":"Simpson","year":"2008","journal-title":"Cancer Lett"},{"key":"2022060800312806200_bib4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/path.3000","article-title":"Anoikis: an emerging hallmark in health and diseases","volume":"226","author":"Taddei","year":"2012","journal-title":"J Pathol"},{"key":"2022060800312806200_bib5","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1158\/0008-5472.CAN-12-1772","article-title":"The V-ATPase-inhibitor archazolid abrogates tumor metastasis via inhibition of endocytic activation of the Rho-GTPase Rac1","volume":"72","author":"Wiedmann","year":"2012","journal-title":"Cancer Res"},{"key":"2022060800312806200_bib6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrm2272","article-title":"Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology","volume":"8","author":"Forgac","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022060800312806200_bib7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7164\/antibiotics.56.520","article-title":"Archazolids, new cytotoxic macrolactones from Archangium gephyra (Myxobacteria). Production, isolation, physico-chemical and biological properties","volume":"56","author":"Sasse","year":"2003","journal-title":"J. Antibiot (Tokyo)"},{"key":"2022060800312806200_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2091-6-13","article-title":"Archazolid and apicularen: novel specific V-ATPase inhibitors","volume":"6","author":"Huss","year":"2005","journal-title":"BMC Biochem"},{"key":"2022060800312806200_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nrc1886","article-title":"Metastasis: a question of life or death","volume":"6","author":"Mehlen","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2022060800312806200_bib10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1083\/jcb.124.4.619","article-title":"Disruption of epithelial cell-matrix interactions induces apoptosis","volume":"124","author":"Frisch","year":"1994","journal-title":"J Cell Biol"},{"key":"2022060800312806200_bib11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0955-0674(00)00251-9","article-title":"Anoikis mechanisms","volume":"13","author":"Frisch","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"2022060800312806200_bib12","doi-asserted-by":"crossref","first-page":"306879","DOI":"10.1155\/2012\/306879","article-title":"Anoikis resistance: an essential prerequisite for tumor metastasis","volume":"2012","author":"Kim","year":"2012","journal-title":"Int J Cell Biol"},{"key":"2022060800312806200_bib13","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/sj.cdd.4401723","article-title":"Anoikis","volume":"12","author":"Gilmore","year":"2005","journal-title":"Cell Death Differ"},{"key":"2022060800312806200_bib14","doi-asserted-by":"crossref","first-page":"738137","DOI":"10.1155\/2011\/738137","article-title":"Integrin signaling, cell survival, and anoikis: distinctions, differences, and differentiation","volume":"2011","author":"Vachon","year":"2011","journal-title":"J Signal Transduct"},{"key":"2022060800312806200_bib15","first-page":"973","article-title":"Signalling mechanisms of anoikis","volume":"19","author":"Zhan","year":"2004","journal-title":"Histol. Histopathol"},{"key":"2022060800312806200_bib16","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.bcp.2008.07.023","article-title":"Anoikis: a necessary death program for anchorage-dependent cells","volume":"76","author":"Chiarugi","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"2022060800312806200_bib17","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/0008-5472.CAN-08-0952","article-title":"Caspase-8: fly or die","volume":"68","author":"Frisch","year":"2008","journal-title":"Cancer Res"},{"key":"2022060800312806200_bib18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ncb1026","article-title":"Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis","volume":"5","author":"Reginato","year":"2003","journal-title":"Nat Cell Biol"},{"key":"2022060800312806200_bib19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1091\/mbc.e07-10-1092","article-title":"Induction of autophagy during extracellular matrix detachment promotes cell survival","volume":"19","author":"Fung","year":"2008","journal-title":"Mol Biol Cell"},{"key":"2022060800312806200_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2012.05.040","article-title":"Bim inhibits autophagy by recruiting Beclin 1 to microtubules","volume":"47","author":"Luo","year":"2012","journal-title":"Mol Cell"},{"key":"2022060800312806200_bib21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00424-007-0382-4","article-title":"V-ATPase functions in normal and disease processes","volume":"457","author":"Hinton","year":"2009","journal-title":"Pflugers Arch"},{"key":"2022060800312806200_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/ncb2652","article-title":"A human genome-wide screen for regulators of clathrin-coated vesicle formation reveals an unexpected role for the V-ATPase","volume":"15","author":"Kozik","year":"2013","journal-title":"Nat Cell Biol"},{"key":"2022060800312806200_bib23","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1600-0854.2012.01327.x","article-title":"Distinct recycling of active and inactive \u03b21 integrins","volume":"13","author":"Arjonen","year":"2012","journal-title":"Traffic"},{"key":"2022060800312806200_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/abio.1995.1318","article-title":"A microplate assay for quantitation of anchorage-independent growth of transformed cells","volume":"228","author":"Fukazawa","year":"1995","journal-title":"Anal Biochem"},{"key":"2022060800312806200_bib25","first-page":"303","article-title":"Mitogen-activated protein\/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway","volume":"1","author":"Fukazawa","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"2022060800312806200_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J Immunol Methods"},{"key":"2022060800312806200_bib27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0955-0674(97)80124-X","article-title":"Integrins and anoikis","volume":"9","author":"Frisch","year":"1997","journal-title":"Curr Opin Cell Biol"},{"key":"2022060800312806200_bib28","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1074\/jbc.274.3.1541","article-title":"The role of c-FLIP in modulation of CD95-induced apoptosis","volume":"274","author":"Scaffidi","year":"1999","journal-title":"J Biol Chem"},{"key":"2022060800312806200_bib29","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1158\/1535-7163.MCT-09-0685","article-title":"Bim-targeted cancer therapy: a link between drug action and underlying molecular changes","volume":"8","author":"Akiyama","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"2022060800312806200_bib30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ceb.2005.10.001","article-title":"Life in the balance: how BH3-only proteins induce apoptosis","volume":"17","author":"Willis","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"2022060800312806200_bib31","doi-asserted-by":"crossref","first-page":"16400","DOI":"10.1074\/jbc.M901201200","article-title":"Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells","volume":"284","author":"Hinton","year":"2009","journal-title":"J Biol Chem"},{"key":"2022060800312806200_bib32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ctrv.2009.08.003","article-title":"V-ATPase inhibitors and implication in cancer treatment","volume":"35","author":"P\u00e9rez-Say\u00e1ns","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"2022060800312806200_bib33","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1016\/j.bmcl.2008.07.003","article-title":"Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide","volume":"18","author":"Lebreton","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"2022060800312806200_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/jpet.107.128587","article-title":"Antimetastatic effect of a small-molecule vacuolar H+\u2212ATPase inhibitor in in vitro and in vivo preclinical studies","volume":"324","author":"Supino","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"2022060800312806200_bib35","doi-asserted-by":"crossref","first-page":"C1443","DOI":"10.1152\/ajpcell.00407.2003","article-title":"Vacuolar H+\u2212ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity","volume":"286","author":"Sennoune","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"2022060800312806200_bib36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1091\/mbc.e12-09-0662","article-title":"\u03b2-Catenin-dependent lysosomal targeting of internalized tumor necrosis factor-\u03b1 suppresses caspase-8 activation in apoptosis-resistant colon cancer cells","volume":"24","author":"Han","year":"2013","journal-title":"Mol Biol Cell"},{"key":"2022060800312806200_bib37","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ijc.28079","article-title":"Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer","volume":"133","author":"Hendrix","year":"2013","journal-title":"Int J Cancer"},{"key":"2022060800312806200_bib38","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/cdd.2008.3","article-title":"Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival","volume":"15","author":"Giannoni","year":"2008","journal-title":"Cell Death Differ"},{"key":"2022060800312806200_bib39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/1541-7786.MCR-12-0551","article-title":"Targeting constitutively activated \u03b21 integrins inhibits prostate cancer metastasis","volume":"11","author":"Lee","year":"2013","journal-title":"Mol Cancer Res"},{"key":"2022060800312806200_bib40","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1242\/jcs.01490","article-title":"FLICE\/caspase-8 activation triggers anoikis induced by beta1-integrin blockade in human keratinocytes","volume":"117","author":"Marconi","year":"2004","journal-title":"J Cell Sci"},{"key":"2022060800312806200_bib41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/BST0360229","article-title":"Integrin activation","volume":"36","author":"Banno","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"2022060800312806200_bib42","doi-asserted-by":"crossref","first-page":"10744","DOI":"10.1158\/0008-5472.CAN-07-3148","article-title":"Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis","volume":"67","author":"Woods","year":"2007","journal-title":"Cancer Res"},{"key":"2022060800312806200_bib43","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.molcel.2009.09.030","article-title":"Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis","volume":"36","author":"Kim","year":"2009","journal-title":"Mol Cell"},{"key":"2022060800312806200_bib44","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1083\/jcb.200211118","article-title":"Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion","volume":"161","author":"Chiarugi","year":"2003","journal-title":"J Cell Biol"},{"key":"2022060800312806200_bib45","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1089\/ars.2005.7.578","article-title":"Anchorage-dependent cell growth: tyrosine kinases and phosphatases meet redox regulation","volume":"7","author":"Chiarugi","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"2022060800312806200_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccr.2011.01.018","article-title":"Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors","volume":"19","author":"Zhu","year":"2011","journal-title":"Cancer Cell"}],"container-title":["Molecular Cancer Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/mct\/article-pdf\/13\/4\/926\/2327578\/926.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/mct\/article-pdf\/13\/4\/926\/2327578\/926.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T20:58:14Z","timestamp":1654635494000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/mct\/article\/13\/4\/926\/91789\/V-ATPase-Inhibition-Regulates-Anoikis-Resistance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,6]]},"published-print":{"date-parts":[[2014,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1535-7163.mct-13-0484","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1535-7163.22499590","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1535-7163.22499593","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1535-7163.22499590.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1535-7163.c.6536188","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1535-7163.22499593.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1535-7163.c.6536188.v1","asserted-by":"object"}]},"ISSN":["1535-7163","1538-8514"],"issn-type":[{"value":"1535-7163","type":"print"},{"value":"1538-8514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,1]]}}}